Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASB12 encodes a protein with N-terminal ankyrin repeats for substrate recognition and a C-terminal SOCS box that mediates assembly with Elongin B/C, Cullin5, and Rbx2, forming part of a multi-subunit Cullin-RING E3 ubiquitin ligase[1][5][6]. The ASB family facilitates targeted protein ubiquitination and degradation through this scaffold, although the biological targets and clinical significance of ASB12 remain unclear; other ASB proteins play roles in cell growth regulation and hematopoietic differentiation, but ASB12 itself is not well characterized[1][7]. No evidence currently supports its direct involvement as a therapeutic target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat and SOCS box protein 12 (ASB12).